To the issue of spontaneous oncogenetic transformation of pluripotent mesenchymal stromal stem cells

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription or Fee Access

Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation

Caplan A.I., Dennis J.E.Mesenchymal stem cells as trophic mediators. J. Cell Biochem. 2006; 98(5): 1076-84.
Caplan A.I., Bruder S.P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. T rends Mol. Med. 2001; 7(6): 259-64.
http://www.osiristx.com/clinical_trials.php.
Riggi N., Cironi L., Provero P. et al. Development of Ewing’s sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res. 2006; 65: 11459-68.
Rubio D., Garcia-Castro J., Martin MC, de la Fuente R. et al. Spontaneous human adult stem cell transformation. Cancer Res. 2005; 65(8): 3035-9.
Miura M., Miura Y., Padilla-Nash H.M. et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stemcells leads to malignant transformation. Stem Cells 2006; 24(4): 1095-103.
Wang Y., Huso D.L., Harrington J. et al. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy 2005; 7(6): 509-19.
Tolar J., Nauta A.J., Osborn M.J. et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007; 25(2): 371-9.
Dominici M., Le Blanc K., Mueller I. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8(4): 315-7.

Supplementary Files

Action

1. JATS XML